<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-vaccines-08-00098">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lavender</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>Williamson</surname>
    <given-names>B.N.</given-names>
   </name>
   <name>
    <surname>Saturday</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Martellaro</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Griffin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hasenkrug</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>Feldmann</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Prescott</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Pathogenicity of Ebola and Marburg Viruses Is Associated with Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice</article-title>
  <source>J. Infect. Dis.</source>
  <year>2018</year>
  <volume>218</volume>
  <fpage>S409</fpage>
  <lpage>S417</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jiy269</pub-id>
  <pub-id pub-id-type="pmid">30085162</pub-id>
 </element-citation>
</ref>
